BioTech Health X delivers the latest biotechnology news, health coverage, genomics, biotech news and stock analysis keeping you informed on the sector.
Joined April 2021
- Tweets 859
- Following 394
- Followers 975
- Likes 234
7 Photos and videos
Jun 14
$CPRX Catalyst Pharmaceuticals (CPRX) may not be the wildest biotech name on Wall Street, but that may be its biggest advantage. With profits, revenue, and rare disease exposure, this small-cap healthcare stock offers a more stable twist on biotech investing. biotechhealthx.com/biotech-n…
105
Jun 14
$OCUL Frequent eye injections are a major burden for patients with wet AMD and diabetic retinopathy. @OCUTX Inc. (NASDAQ: OCUL) is trying to change that with its hydrogel-based sustained-release technology. biotechhealthx.com/biotech-n…
1
2
680
Jun 14
$AUPH @AuriniaPharma Inc. (NASDAQ:AUPH) is not just another risky biotech story. With Lupkynis, real revenue, growing profits, and 2026 guidance, this commercial-stage biotech stock deserves investor attention. biotechhealthx.com/biotech-n…
162
Jun 14
$ARQT @ArcutisBio (NASDAQ: ARQT) is not just another small-cap biotech waiting for future trial results. With ZORYVE driving $105.4 million in Q1 2026 net product revenue, ARQT is showing real commercial momentum. biotechhealthx.com/biotech-n…
1
131
Jun 14
$TRVI @TreviThera Inc. (NASDAQ: TRVI) is gaining attention among small-cap biotech stocks thanks to Haduvio, its focused pipeline, and a cash runway expected to stretch into 2030. Is this under-the-radar biotech stock quietly building a stronger case for investors? biotechhealthx.com/biotech-n…
1
1
201
Jun 14
$IOVA @IovanceBio (IOVA) is not your ordinary biotech story. With Amtagvi already on the market and 2026 revenue guidance in focus, this cancer cell therapy stock could become one of the most watched high-risk biotech names this year. biotechhealthx.com/biotech-n…
1
3
7
628
Jun 14
$NRIX @Nurix_Tx Therapeutics Inc. (NASDAQ: NRIX) is building momentum with bexobrutideg, a BTK degrader expected to enter Phase 3 trials for CLL. Could this @Roche-backed biotech become a standout small-cap stock? biotechhealthx.com/biotech-n…
118
Jun 14
$EWTX @EdgewiseTx Therapeutics Inc. (NASDAQ:EWTX) has gained attention after a major deal helped strengthen its balance sheet and sharpen its focus on cardiovascular drug development. biotechhealthx.com/biotech-n…
392
Jun 14
$KALV @KalVista Pharmaceuticals (NASDAQ: KALV) became a special-case biotech after @ChiesiGroup's $1.9 billion acquisition agreement. This rare disease stock now offers a lesson in how Big Pharma hunts for valuable biotech assets. biotechhealthx.com/biotech-n…
42
Jun 14
$REPL @Replimune Group Inc. (NASDAQ: REPL) is back on biotech investors’ radar after a painful FDA setback and a possible second shot for RP1. Is this cancer biotech stock a risky trap or a turnaround story worth watching? biotechhealthx.com/biotech-n…
2
188
Jun 12
$ARQT $AUPH $CPRX $OCUL $TRVI From cancer cell therapy to rare disease treatments and eye-disease breakthroughs, these small-cap biotech stocks are chasing major medical markets. Here are 10 biotech companies drawing attention for their pipelines, revenue growth, and upside potential. biotechhealthx.com/biotech-n…
298
Jun 12
$EWTX $IOVA $NRIX $KALV $REPL Small-cap biotech stocks are heating up as investors hunt for FDA catalysts, rare disease breakthroughs, cancer treatments, and Big Pharma buyout potential. These 10 biotech names could be among the most interesting stocks to watch now. biotechhealthx.com/biotech-n…
2
3
2,174
$OVID @OvidRx (NASDAQ: OVID) is not the loudest biotech penny stock under $5, but its stronger cash runway, neurology-focused pipeline, and improved balance sheet could make it one of the more interesting small-cap healthcare stocks to watch this June. biotechhealthx.com/biotech-n…
268
$CRBU @CaribouBio (NASDAQ: CRBU) is not your typical biotech penny stock. With FDA alignment on its pivotal ANTLER-3 trial for vispa-cel, this small-cap gene-editing player could be one of the most intriguing oncology stocks under $5 to watch this June. biotechhealthx.com/biotech-n…
2
6
519
$MIST Milestone Pharmaceuticals is not your typical cancer-drug penny stock story. With CARDAMYST now commercially available, Express Scripts coverage, and a cash runway into 2027, MIST may be one of the more serious NASDAQ biotech penny stocks to watch this June. biotechhealthx.com/biotech-n…
1
341
$NRXP @NRxPharma is getting fresh attention as traders watch NRX-100, KETAFREE, FDA-related updates, and improving Q1 2026 losses. Is NRXP one of June’s most explosive biotech penny stocks, or just another high-risk name built for volatility? biotechhealthx.com/biotech-n…
3
299
$INAB @In8bio Inc. (NASDAQ: INAB) may be small, risky, and volatile, but its glioblastoma program and low market cap are putting this biotech penny stock on the radar of aggressive traders looking for explosive healthcare stocks under $5. biotechhealthx.com/biotech-n…
1
1
157